Quality Not Quantity
Increased Biopharma Patent Valuation Fuels Litigation
By Mari Serebrov
Monday, January 30, 2012
In an economy gasping for air, patents are increasingly becoming the oxygen of biopharma, fueling a litigation process that fans their value even more.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.